Pediatric Obesity Treatment in Children With Neurodevelopmental Disabilities: A Case Series and Review of the Literature.

Infant Child Adolesc Nutr

Department of Pediatrics, Wake Forest University School of Medicine (MBI, SK, JAS) and Brenner FIT Program, Brenner Children's Hospital (MBI, DE-G, JAS), Winston-Salem, North Carolina.

Published: August 2012

AI Article Synopsis

  • Obesity is more prevalent in children with developmental disabilities, yet treatments have mostly targeted nondisabled children.
  • Current research on adapting obesity treatments for youth with neurodevelopmental disabilities is limited and highlights the need for tailored approaches.
  • A family-based, multidisciplinary weight management program offers insights from clinical experience addressing obesity by collaborating with families, establishing healthy routines, and adjusting treatment progression.

Article Abstract

Obesity can affect any child, but it occurs disproportionately in children with developmental disabilities. Treatment efforts, however, have focused primarily on nondisabled children, and more research is needed to determine how current approaches can be modified for youth with neurodevelopmental disabilities. This article briefly reviews what is currently known about obesity treatment in these children and presents a case series describing methods employed by a family-based, multidisciplinary weight management program in the treatment of obesity. Lessons learned from clinical experience are also discussed, with implications for collaborating with families of children with disabilities in treatment, establishing healthy routines and schedules, setting the pace of treatment progression, and minimizing disruptions in the behavior change process. Though there are no expert recommendations specifically tailored to obesity treatment in children with neurodevelopmental disabilities, existing clinical programs such as the one described here can be adapted to better meet the needs of this underserved population. Further research is warranted to determine the most effective methods for addressing obesity in these children, as has been specified as a national health priority.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3979556PMC
http://dx.doi.org/10.1177/1941406412448527DOI Listing

Publication Analysis

Top Keywords

obesity treatment
12
treatment children
12
neurodevelopmental disabilities
12
children neurodevelopmental
8
case series
8
disabilities treatment
8
treatment
7
children
7
disabilities
5
obesity
5

Similar Publications

Effects of Tinospora cordifolia (giloy) on metabolic syndrome components: a mechanistic review.

Naunyn Schmiedebergs Arch Pharmacol

December 2024

Department of Pharmacodynamics and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.

Metabolic syndrome is a cluster of some conditions such as high blood sugar, high blood triglycerides, low HDL cholesterol, abdominal obesity, and high blood pressure. Introducing a drug or a food that manages the majority of these medical conditions is invaluable. Tinospora cordifolia, known as guduchi and giloy, is a medicinal herb in ayurvedic medicine that is used in the treatment of various diseased conditions and also as a food for the maintenance of health.

View Article and Find Full Text PDF

Background: Nonalcoholic fatty liver disease (NAFLD) has developed as a leading public wellness challenge as a result of changes in dietary patterns. Unfortunately, there is still a lack of effective pharmacotherapy methods for NAFLD. Wang's empirical formula (WSF) has demonstrated considerable clinical efficacy in treating metabolic disorders for years.

View Article and Find Full Text PDF

Background: Adrenocorticotropin (ACTH)-dependent Cushing's syndrome can arise from a pituitary tumour (Cushing's disease) or an ectopic ACTH-secreting tumour, making precise differentiation essential for effective treatment. Bilateral inferior petrosal sinus sampling (BIPSS) is the gold standard for this differentiation, but false-negative results can limit its accuracy. Adding prolactin (PRL) measurement to BIPSS has been proposed to improve diagnostic precision.

View Article and Find Full Text PDF

Outcomes and complications after long versus short gastric pouch Roux-en-Y gastric bypass in patients with severe obesity.

Sci Rep

December 2024

Department of Surgery, Minimally Invasive Surgery Research Center, Division of Minimally Invasive and Bariatric Surgery, Hazrat-E Fatemeh Hospital, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.

Roux-en-Y gastric bypass (RYGB) is the second most common metabolic and bariatric surgery (MBS) globally. The impact of pouch size on weight loss outcomes and complications remains unclear. This study aims to compare the weight loss outcomes and complications in long pouch versus short pouch RYGB in patients with severe obesity.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!